Megakaryon
1 known investors
Megakaryon is a Japanese regenerative-medicine venture developing platelet products derived from human iPS cells, including HLA-homozygous iPS-cell-derived platelets (MEG-002) that have advanced into clinical trials. It became a subsidiary of Sysmex Corporation in 2023.
Investors · 1
Frequently asked questions
- What does Megakaryon do?
- Megakaryon is a Japanese regenerative-medicine venture developing platelet products derived from human iPS cells, including HLA-homozygous iPS-cell-derived platelets (MEG-002) that have advanced into clinical trials. It became a subsidiary of Sysmex Corporation in 2023.
- Who are Megakaryon's investors?
- Megakaryon's investors include Miyako Capital.